Abstract
Frailty is a syndrome that includes broad problems of senility and consists of three domains: physical, psychological, and social. Kampo medicine is used for intervention in cases of hypofunction in a mental or physical state. Kampo treatment, using Hojin formulations such as Hachimijiogan and Gosyajinkigan, is useful in patients with "jinkyo," or kidney hypofunction. Ketsu includes both blood and its metabolic products that circulate throughout the body. Oketsu is a disturbance of ketsu and is considered to be a microcirculation disorder. Anti-oketsu formulations, such as Keishibukuryogan and Jidabokuippo, are useful in the treatment of trauma patients who are experiencing swelling and pain. "Ki" is the universal energy that exists in the world. Hoki formulations, such as Rikkunshito and Hochuekkito, are useful in patients with poor appetites for reinforcing vital energy. Juzentaihoto and Ninjinyoeito are useful in patients with hypofunction of ki and ketsu, which are accompanying symptoms of coldness or cutaneous dryness. Thus, Kampo medicines can be used as a superior approach for the management of frailty.
References
Aug 1, 1994·International Journal of Immunopharmacology·Y FujiiT Miyazaki
Apr 15, 1999·Japanese Journal of Pharmacology·Y SuzukiJ Kamei
May 7, 1999·Japanese Journal of Pharmacology·Y SuzukiJ Kamei
Mar 17, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·L P FriedUNKNOWN Cardiovascular Health Study Collaborative Research Group
Feb 16, 2008·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Kozo Nakamura
Oct 9, 2008·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Qian-Li XueLinda P Fried
Apr 16, 2010·Age and Ageing·Alfonso J Cruz-JentoftUNKNOWN European Working Group on Sarcopenia in Older People
Aug 14, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Hajime NakaeAkira Horikawa
Oct 15, 2013·Cancer Chemotherapy and Pharmacology·Toru KonoHideyuki Mishima
May 9, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·K WatanabeI Takei
Jan 30, 2015·International Journal of Clinical Oncology·Eiji OkiYoshihiko Maehara
Feb 1, 2015·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Yuki KishidaKeisuke Hagihara
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Gianfranco SpallettaMaria D Orfei
Mar 11, 2016·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Hiroyasu SatohKatsuharu Tsuchida
Jun 15, 2016·Molecular Pain·Miho NakanishiKeisuke Hagihara
Jul 5, 2016·Clinical Reviews in Bone and Mineral Metabolism·Kozo Nakamura, Toru Ogata
Dec 27, 2016·Annals of Vascular Diseases·Koji KawagoHitoshi Ogino
Apr 18, 2017·Current Alzheimer Research·Gotaro KojimaKate Walters
Dec 28, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Akira Kuriyama, Koji Endo
Mar 14, 2018·Modern Rheumatology·Manabu AkahaneTomoaki Imamura
Nov 28, 2018·JAD Reports·Makoto OhsawaKosuke Onaka
Citations
Oct 24, 2018·Frontiers in Nutrition·Kanako MiyanoYasuhito Uezono
Feb 2, 2019·Frontiers in Nutrition·Keiko Ogawa-Ochiai, Kanji Kawasaki
Feb 9, 2019·PloS One·Chi-Hsien HuangMasafumi Kuzuya
Apr 20, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Tatsuya IshigeToshihiko Hanawa